PARTICULARITY OF CLINIC COURSE OF ARTERIAL HYPERTENSION ON THE VBACKGROUND OF OBESITY AND NONALCOHOLIC FATTY LIVER DISEASE DEPENDING ON THE GENDER FEATURES

Authors

  • O. M. Bochar Danylo Galytsky Lviv National Medical University

DOI:

https://doi.org/10.11603/2415-8798.2017.2.7823

Keywords:

hypertension, obesity, nonalcoholic steatohepatitis, interleukin-6, leptin, 13C-methacetin breathe test.

Abstract

In Ukraine, the structure of the share of total mortality for cardiovascular disease (CVD) accounts for 62.5–63.4 %. In particular, at least 75–80 % of deaths from cardiovascular disease are associated with atherosclerotic blood vessels, namely: hypertension (HT), myocardial infarction and stroke.

The aim of the study – to make a comparative evaluation of anthropometric, instrumental and laboratory indicators in patients with arterial hypertension combined with obesity and non-alcoholic steatohepatitis, depending on gender features.

Materials and Methods. 110 patients were divided into groups on the basis of gender. There were 42 men (38.2 %), 68 women –  (61.8 %). Patients underwent anthropometric and series of instrumental and laboratory studies.

Results and Discussion. Comparing the anthropometric indices, it was revealed that men were significantly dominated by height, weight and waist circumference. However, according to the average BMI value, there is no reliable difference between men and women – respectively, 32.94±0.54 kg/m2 in men versus 34.32±0.41 kg/m2 – in women. According to echocardiography, left ventricular and left atrial hypertrophy was the same in men and women, this correlates with the growth of body mass index equally in both sexes. The average levels of total cholesterol, high-density lipoproteins, medium-density lipoproteins and triglycerides, as well as the level of total bilirubin among men and women, did not differ significantly. Certain differences in hepatic transaminase activity were noted. The average value of ALT in men was 1.97± 0.82 mmol/(hour×l), in women – 0.64±0.05 mmol/(hour×l). The level of AST was also higher in men (1.74±0.81 mmol/(hour×l) vs. 0.53±0.02 mmol/(hour×l) – in women, indicating that it was in men who frequently developed steatohepatitis. In women, the average leptin concentration was 45.63±9.06 ng/ml and was higher than in men (35.94±8.12 ng/ml). The levels of interleukin-6 among women and men did not differ significantly and amounted to 8.46±1.02 pg/ml and 7.98±0.86 pg/ml, respectively. According to the results of the 13C-methacetin breath test, the metabolic rate among women and men was not significantly different.

Conclusions. In patients with arterial hypertension combined with obesity and non-alcoholic steatohepatitis, there were no gender differences in anthropometric examinations, ultrasound examination of the heart and liver, and also in the lipidogram. A significant increase in the mean levels of hepatic transaminases in men was diagnosed, which indicated the frequent occurrence of steatohepatitis in them. In women we noted a significant increase in the level of leptin.

Author Biography

O. M. Bochar, Danylo Galytsky Lviv National Medical University

аспірант кафедри терапії №1 та медичної діагности ФПДО Львівського національного медичного університету імені Данила Галицького м. Львів, Адреса: м. Львів, вул. Мазепи Гетьмана, буд.1,  кв. 12 +380971339957

References

Amosova, E.N. (2011). Ot lecheniya ateroskleroza k modifikatsii prognoza: fokus na lipidosnizhayushchuyu terapiyu. Chast 1 [From the treatment of atherosclerosis to the modification of the prognosis: a focus on lipid-lowering therapy. Part I]. Sertse i sudyny – Heart and Vessels, (1), 6-19 [in Russian].

Herasimova, A.S., Oleynikov, B.E., & Eliseeva, I.V. (2008). Osobennosti techeniya i porazheniya organov-misheney pri metabolicheskom syndrome [Features of the course of arterial hypertension and lesion of target organs in metabolic syndrome]. Mezhdunarodnyy meditsynskiy zhurnal – International Medical Journal, (3), 22-29 [in Russian].

Hubergrits N.B., & Lareva N.V. (2011). Statiny v gepatologii: “Tsarevna lyagushka” ili “zhaba”? [Statins in hepatology: "princess-frog" or "toad"?]. Suchasna hastroenterolohiia – Modern Gastroenterology, (6), 78-91 [in Russian].

Dolzhenko, N.M. (2008). Novi aspekty zastosuvannia ursodeksokholiievoi kysloty: pohliad kardioloha [New aspects of ursodexocholic acidl: view of cardiologist]. Zdoroviia Ukrainy. XXI storichchia – Health of Ukraine. XXI century, (15-16). Retreived from: http://health-ua.com/article/2879.html [in Ukrainian].

Solomenchuk, T.M., Slaba, N.A., Chnhrian, h.V., Klymkovych, O.Yu., Slabyi, O.M., Poltorak L.V., & Protsko, V.V. (2013). Efektyvnist rozuvastatynu u khvorykh na arterialnu hipertenziiu vysokoho kardiovaskuliarnoho ryzyku [The effectiveness of rosuvastatin in patients with hypertension high cardiovascular risk]. Liky Ukrainy – Remedies of Ukraine, (9-10), 82-89 [in Ukrainian].

Khukhlina, O.S., & Horbatiuk, I.B. (2011). Doslidzhennia vplyvu rozuvastatynu ta mosaprydu na zminy lipidnoho spektru krovi, stupin insulinorezystentnosni ta litohennosti zhovchi u khvorykh z poiednanym perebihom protikannia nekamenevoho kholetsystytu iz ozhyrinniam ta ishemichnoiu khvoroboiu sertsia [The influence of rosuvastatin and mosapride on changes in lipid profile, the degree of bile insulin resistance and lithogenicity in patients with combined flow acalculous cholecystitis with obesity and coronary heart disease]. Klinichna ta eksperymentalna patolohiia – Clinical and Experimental Pathology, (3), 143-147 [in Ukrainian].

Kravchun, P.H., & Kadykova, O.S. (2010). Vzaiemozviazok stupenia insulinorezystentnosti z arterialnoiu hipertenziieiu u khvoryh na tsukrovyi diabet 2 typu [The relationship of the degree of severity of insulin resistance in hypertensive patients with type 2 diabetes]. Medytsyna siohodni i zavtra – Medicine Today and Tomorrow, (4), 49-54 [in Ukrainian].

Vlasova S.V., Ilchenko M.Yu., & Kazakova E.B. (2010). Disfunktsia endothelia i arterialnaya gipertenziia [Endothelium dysfunction and arterial hypertension]. Lebedev, P.A. (Ed.). Samara: OOO “Ofort” [in Russian].

Konopleva, L.F. (2011). Endotelialnaya disfunktsiya v patogeneze serdechno-sosudistykh zabolevaniy i matody ee korrektsii [Endothelial dysfunction in the pathogenesis of cardiovascular diseases and methods of its correction]. Therapia, (3), 26-30 [in Russian].

Jones, T.H. (2008). Testosteron Deficiency in Men. Oxford University Press.

Jones, T.H. (2010). Testosterone deficiency: a risk factor for cardiovascular disease? Trends. Endocrinol. Metab., (21), 496–503.

Jones, T.H. (2009). The effect of testosterone in risk factors, and the mediators of the atherosclerosis process. Atherosclerosis, (2), 318–327.

Barna, О.М. (2008). Henderna medytsyna: proektsia na sertsevu farmakoterapiiu (ohliad literatury) [Gender medicine: proection on the heart pharmacotherapy]. Liky Ukrainy – Remedies of Ukraine, (4), 165-171 [in Ukrainian].

Published

2017-08-17

How to Cite

Bochar, O. M. (2017). PARTICULARITY OF CLINIC COURSE OF ARTERIAL HYPERTENSION ON THE VBACKGROUND OF OBESITY AND NONALCOHOLIC FATTY LIVER DISEASE DEPENDING ON THE GENDER FEATURES. Bulletin of Scientific Research, (2). https://doi.org/10.11603/2415-8798.2017.2.7823

Issue

Section

INTERNAL MEDICINE